TP53 and neuroblastoma: The combination of MDM2 (an E3-ubiquitin ligase involved in proteasomal degradation of p53) inhibitor (CGM097) and OTX015 results in p53 activation and decreased expression of MYC proteins, which synergistically promotes neuroblastoma cell death (79).